PPP2R5D Neurodevelopmental Disorder: Clinical Trials

1 active not recruiting. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Active not recruiting 1

Follow PPP2R5D Neurodevelopmental Disorder: new trials by email Literature Review of PPP2R5D Neurodevelopmental Disorder trials Research Report on PPP2R5D Neurodevelopmental Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) BPN14770, Placebo - Jordan's Syndrome, PPP2R5D Neurodevelopmental Disorder	Phase 2	Active not recruiting	Shionogi	30	2025-05-13	2026-06-09

Interventions

BPN14770 (1)

Sponsors

Shionogi (1)

Countries

United States (1)